COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,358 Articles (22,803 medRxiv, 8,555 bioRxiv)

Most recent first Previous |  Page 1415: Articles 14141-14150  | Next

Men and loneliness in the Covid-19 pandemic: insights from an interview study with UK-based men
Ratcliffe, J., Galdas, P., Kanaan, M.
10.1101/2021.06.30.21259536 — Posted: 2021-07-05
Importance of epidemic severity and vaccine mode of action and availability for delaying the second vaccine dose
Berec, L., Levinsky, R., Weiner, J., Smid, M., Neruda, R., Vidnerova, P., Suchoparova, G.
10.1101/2021.06.30.21259752 — Posted: 2021-07-05
Implications of COVID-19 vaccination and public health countermeasures on SARS-CoV-2 variants of concern in Canada: evidence from a spatial hierarchical cluster analysis
Adeyinka, D. A., Camillo, C., Marks, W., Muhajarine, N.
10.1101/2021.06.28.21259629 — Posted: 2021-07-05
COVID-19 vaccine hesitancy and refusal and associated factors in an adult population in Saskatchewan, Canada: Evidence from predictive modelling
Muhajarine, N., Adeyinka, D. A., McCutcheon, J., Green, K. L., Fahlman, M., Kallio, N.
10.1101/2021.06.28.21259675 — Posted: 2021-07-05
Network-based identification and pharmacological targeting of host cell master regulators induced by SARS-CoV-2 infection
Laise, P., Stanifer, M. L., Bosker, G., Sun, X., Triana, S., Doldan, P., La Manna, F., De Menna, M., Realubit, R. B., Pampou, S., Karan, C., Alexandrov, T., Kruithof-de Julio, M., Califano, A., Boulant, S., Alvarez, M. J.
10.1101/2021.07.03.451001 — Posted: 2021-07-04
Allotypic variation in antigen processing controls antigenic peptide generation from SARS-CoV-2 S1 Spike Glycoprotein
Stamatakis, G., Samiotaki, M., Temponeras, I., Panayotou, G., Stratikos, E.
10.1101/2021.07.03.450989 — Posted: 2021-07-04
SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome
Zaffagni, M., Harris, J. M., Patop, I. L., Pamudurti, N. R., Nguyen, S., Kadener, S.
10.1101/2021.07.02.450964 — Posted: 2021-07-04
Transmission event of SARS-CoV-2 Delta variant reveals multiple vaccine breakthrough infections
Farinholt, T., Qin, X., Meng, Q., Menon, V., Doddapaneni, H., Chao, H., Gingras, M.-C., Farinholt, P., Agrawal, C., Muzny, D., Piedra, P. A., Gibbs, R. A., Petrosino, J.
10.1101/2021.06.28.21258780 — Posted: 2021-07-04 Discussion: Onsite | Offsite
Facilitators and Barriers to Compliance with COVID-19 Guidelines: A Structural Topic Modelling Analysis of Free-Text Data from 17,500 UK Adults
Wright, L., Paul, E., Steptoe, A., Fancourt, D.
10.1101/2021.06.28.21259621 — Posted: 2021-07-04
Perceptions and acceptance of COVID-19 vaccine among pregnant and lactating women in Singapore: A cross-sectional study
Jayagobi, P. A., Ong, C., Yeo, K. T., Lim, C. C., Seet, M. J., Kwek, L. K., Ku, C. W., Chan, J., Mathur, M., Chua, M. C.
10.1101/2021.06.29.21259741 — Posted: 2021-07-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).